(0.01%) 5 207.00 points
(0.05%) 39 017 points
(-0.07%) 18 183 points
(0.14%) $78.59
(-1.28%) $2.17
(-0.09%) $2 329.00
(-0.50%) $27.48
(0.34%) $968.20
(0.10%) $0.929
(0.23%) $10.85
(0.15%) $0.797
(-0.24%) $91.13
2 days till quarter result
(amc 2024-05-09)
Expected move: +/- 13.42%
-2.29% $ 1.280
Live Chart Being Loaded With Signals
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space...
Stats | |
---|---|
Dzisiejszy wolumen | 147 619 |
Średni wolumen | 385 041 |
Kapitalizacja rynkowa | 95.64M |
EPS | $0 ( 2024-03-12 ) |
Następna data zysków | ( $-0.140 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.42 |
ATR14 | $0.00500 (0.38%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-18 | Gibney Anthony S | Buy | 93 290 | Common Stock |
2024-04-17 | Gibney Anthony S | Buy | 6 710 | Common Stock |
2024-04-15 | Gibney Anthony S | Buy | 45 000 | Stock Option (right to buy) |
2024-04-15 | Gibney Anthony S | Buy | 0 | |
2024-03-20 | Chong Ngai Hang Victor | Buy | 30 000 | Common Stock |
INSIDER POWER |
---|
66.98 |
Last 97 transactions |
Buy: 5 495 368 | Sell: 2 175 231 |
Wolumen Korelacja
Clearside Biomedical Inc Korelacja
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Clearside Biomedical Inc Korelacja - Waluta/Towar
Clearside Biomedical Inc Finanse
Annual | 2023 |
Przychody: | $8.23M |
Zysk brutto: | $7.80M (94.87 %) |
EPS: | $-0.530 |
FY | 2023 |
Przychody: | $8.23M |
Zysk brutto: | $7.80M (94.87 %) |
EPS: | $-0.530 |
FY | 2022 |
Przychody: | $1.33M |
Zysk brutto: | $1.12M (84.63 %) |
EPS: | $-0.570 |
FY | 2021 |
Przychody: | $29.58M |
Zysk brutto: | $29.58M (100.00 %) |
EPS: | $0.00632 |
Financial Reports:
No articles found.
Clearside Biomedical Inc
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase 1/2a clinical trial; and CLS-301, an integrin inhibitor suspension for the treatment of diabetic macular edema and macular degeneration. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej